Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Flow cytometry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN447477 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Lysyl Oxidase (LOX) (AA 118-168), (Internal Region), (Propeptide), (glycosylated) antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified
- Reactivity
- Human, Rat
- Host
- Rabbit
- Epitope
- AA 118-168, Internal Region, Propeptide, glycosylated
- Vial size
- 0.1 mL
- Storage
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
- Handling
- Avoid freeze-thaw cycles
Submitted references Prostaglandin E2 inhibits elastogenesis in the ductus arteriosus via EP4 signaling.
Inhibition of CIN85-mediated invasion by a novel SH3 domain binding motif in the lysyl oxidase propeptide.
The Ras signaling inhibitor LOX-PP interacts with Hsp70 and c-Raf to reduce Erk activation and transformed phenotype of breast cancer cells.
The lysyl oxidase propeptide interacts with the receptor-type protein tyrosine phosphatase kappa and inhibits β-catenin transcriptional activity in lung cancer cells.
Yokoyama U, Minamisawa S, Shioda A, Ishiwata R, Jin MH, Masuda M, Asou T, Sugimoto Y, Aoki H, Nakamura T, Ishikawa Y
Circulation 2014 Jan 28;129(4):487-96
Circulation 2014 Jan 28;129(4):487-96
Inhibition of CIN85-mediated invasion by a novel SH3 domain binding motif in the lysyl oxidase propeptide.
Sato S, Zhao Y, Imai M, Simister PC, Feller SM, Trackman PC, Kirsch KH, Sonenshein GE
PloS one 2013;8(10):e77288
PloS one 2013;8(10):e77288
The Ras signaling inhibitor LOX-PP interacts with Hsp70 and c-Raf to reduce Erk activation and transformed phenotype of breast cancer cells.
Sato S, Trackman PC, Mäki JM, Myllyharju J, Kirsch KH, Sonenshein GE
Molecular and cellular biology 2011 Jul;31(13):2683-95
Molecular and cellular biology 2011 Jul;31(13):2683-95
The lysyl oxidase propeptide interacts with the receptor-type protein tyrosine phosphatase kappa and inhibits β-catenin transcriptional activity in lung cancer cells.
Sánchez-Morgan N, Kirsch KH, Trackman PC, Sonenshein GE
Molecular and cellular biology 2011 Aug;31(16):3286-97
Molecular and cellular biology 2011 Aug;31(16):3286-97
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS